BridgeMD
New treatment option for Frozen Shoulder
Official title 3-Dimensional Shoulder Complex Pain Alignment (3-D SPA) Mobilization on Frozen Shoulder.
ClinicalTrials.gov ID: NCT06530602
What this study is testing
- What it's testing
- Ongoing research aims to assess the enhancement of shoulder mobility by specifically addressing restrictions in all three planes of movement. current studies seek to investigate the impact of three-dimensional mobilization technique on their recovery and to prevent progression of disease to reduce pain, alleviate muscle tightness, facilitate tissue healing, and ultimately improve the range of motion in patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 65
You may be able to join if
- Local shoulder pain, often present either above the antero-medial and Lateral aspect of the shoulder.
- Stage II\& III unilateral frozen shoulder Symptoms.
- Marked loss Of AROM \& PROM with at least 50%loss of external rotation.
- Positive Apley's Scratch test.
You likely can't join if
- Radiculopathy.
- Thoracic-outlet syndrome.
- Fractures and tumors of the upper extremity.
- Neurological disorders causing muscle weakness in the shoulder.
- Corticosteroid injection for frozen shoulder in last 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.